PHENURONE Drug Patent Profile
✉ Email this page to a colleague
When do Phenurone patents expire, and when can generic versions of Phenurone launch?
Phenurone is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in PHENURONE is phenacemide. Additional details are available on the phenacemide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENURONE?
- What are the global sales for PHENURONE?
- What is Average Wholesale Price for PHENURONE?
Summary for PHENURONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 43 |
| Patent Applications: | 2,766 |
| DailyMed Link: | PHENURONE at DailyMed |
US Patents and Regulatory Information for PHENURONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | PHENURONE | phenacemide | TABLET;ORAL | 007707-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
